Clinico-pathological characteristics of patients with stage IB1 –IB2 (FIGO 2018) uterine cervical cancer: a nationwide study in Japan

ConclusionNon-squamous cell carcinoma and intermediate-risk decreased survival in patients with stage IB2, whereas double intermediate-risk was a negative impact on survival in stage IB1.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research